26th Annual Grandon Lecture 
 Vital Directions for Health and Healthcare for the Nation

The Jefferson College of Population Health hosts an annual lecture as a tribute to Raymond C. Grandon, MD. This year, we will celebrate the 26^th Annual Raymond C. Grandon Lecture by bringing Victor J. Dzau, MD, President of the National Academy of Medicine (NAM) to the Jefferson campus to speak on NAM' groundbreaking initiative, Vital Directions for Health and Health Care.

Dr. Dzau will focus on three overarching goals for the United States: better health and well-being; high-value health care; and strong science and technology. He will provide an assessment of the current state of health and healthcare in the United States; describe key directions for US healthcare reform; and examine strategic action priorities and essential infrastructure necessary to achieve a health system that performs optimally in promoting, protecting, and restoring the health of individuals and populations.

Join us on Thursday, May 24^th, from 12:00-2:00 pm for this unique presentation and tribute to Raymond C. Grandon. Lunch will be provided.

Seating is limited, so please register as soon as possible.  Contact Vivian.Castillo@Jefferson.edu with any questions. 

Access the electronic brochure by following this link.

Fireside Chat Moderated by David B. Nash, MD, MBA

Sharon L. Larson, PhD
Executive Director and Professor
Main Line Health Center for Population Health Research at Lankenau Institute for Medical Research
Professor
College of Population Health, Thomas Jefferson University

Jack Ludmir, MD
Senior Vice President, Physician Engagement & Integration
Jefferson Health
Associate Provost, Community & Global Initiatives
Thomas Jefferson University

Edmund Pribitkin, MD, MBA, 
Chief Medical Officer
Thomas Jefferson University Hospitals
President
Jefferson University Physicians

Meet Victor J. Dzau, MD
Dr. Dzau is the President of the National Academy of Medicine (NAM), formerly the Institute of Medicine. In addition, he serves as Vice Chair of the National Research Council. He is an internationally acclaimed leader and scientist whose work has improved health care in the United States and globally. Since arriving at the National Academies, Dr Dzau has led important initiatives such as the Commission on a Global Health Risk Framework for the Future; the Human Gene Editing Initiative; Vital Directions for Health and Health Care; and the NAM Grand Challenges in Healthy Longevity.

His own research laid the foundation for development of a lifesaving class of drugs, ACE inhibitors, used globally to treat high blood pressure and congestive heart failure. He pioneered gene therapy for vascular disease. He is a member of the board of directors of the Singapore Health Services, a former member of the Advisory Committees to the Director of U.S. National Institutes of Health, chaired NIH's Cardiovascular Disease Advisory Committee and is past chair of the Association of Academic Health Centers.

Dr. Dzau has previously served as Chancellor for Health Affairs and President & CEO of Duke University Health system. He has received numerous awards including the Max Delbruck Medal from Germany, the Gustav Nylin Medal from the Swedish Royal College of Medicine, the Polzer Prize from the European Academy of Sciences & Arts, the Ellis Island Medal of Honor, and the Distinguished Scientist Award of the American Heart Association.

About Raymond C. Grandon, MD
Raymond Charles Grandon, MD, a lifelong Pennsylvanian, earned his medical degree from Jefferson Medical College in 1945. He completed a nine month general internship at St. Luke's Hospital in Bethlehem, Pennsylvania, served in the United States Army and completed a residency in internal medicine at the Harrisburg Hospital in Harrisburg Pennsylvania. Dr. Grandon subsequently entered private practice as a solo practitioner.

An internist with a special interest in cardiovascular disease, Dr. Grandon was responsible for the first televised heart operation in the United States. He was a clinical investigator in cardioactive drugs, the first of which was reserpine for hypertension. Dr. Grandon also helped to coordinate the nation's first commercially successful cardiac rehabilitation program utilizing graded exercise with continuous oscilloscope monitoring.

Dr. Grandon has served as a past President of organizations such as Central Pennsylvania Academy of Medicine, Dauphin County Medical Society, the Medical and Dental Bureau of Harrisburg, and the Pennsylvania Society of Internal Medicine. He is past Director of Medical Education at Harrisburg Hospital; and the Founder and past Chairman of the Regional Advisory Group of the Federal Health Program for the Susquehanna Valley Regional Program. Dr. Grandon has also served as Clinical Professor at Penn State Hershey Medical Center, Director of Medical Education at Harrisburg Hospital, Medical Director of a skilled nursing facility, and a member of the JMC Alumni Association Executive Committee. Later, he served as a Trustee to the American Society of Internal Medicine.

Long active in voluntary medical and community organizations, Dr. Grandon has also been involved with medical issues at the state level; as a member of the Governor's Commission on Alcoholism; as the first Medical Director of the Pennsylvania Health Department's Counseling Center on Alcoholism; as a member of the State Board of Medical Education and Licensure; and as a member of the Health Department's Laboratory Advisory General's Advisory Committee and the Attorney General's Advisory Committee on Drug and Alcohol Problems. At the national level, he has served as a committee member of the Federation of State Medical Licensing Boards, and as a Delegate and Trustee of the American Society of Internal Medicine.